soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no soul trial oral semaglutide cardiovascular

Obesity significantly increases the risk of diseases like diabetes, heart disease, and certain cancers

People with kidney disease, eating disorders, pregnancy, gastroparesis, repeated vomiting, or medication-related hypoglycemia need more careful planning

Before your first Ozempic shot, making a few simple dietary adjustments can help your body adapt more comfortably to the medication

Clients who lift weights on Ozempic lose fat

Thus, the medicinal application of nanozyme-based disruptors of hydrogen peroxide homeostasis, enhancing the cellular levels of hydrogen peroxide and preventing its elimination may support the efficacy of chemodynamic therapy

I've not come across the advice re potassium